Normal
6th - 7th October 2022

4th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference UK/EU

ISH Venues, 1 Park Cres, London W1B 1SH, United Kingdom
150+
Attendees
20+
Speakers
10
Networking Hours
5+
Sessions

Leveraging next gen technologies beyond conventional biomarker drug discovery

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

users

20+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Challenges in NGS based CDx and the Importance of imaging biomarkers for precision medicine.

users

Opportunity to develop long-lasting business relationships and networking opportunities with senior peers. Get the Opportunity to get your queries handled by Biomarker experts in one on one session.

users

Facilitated networking sessions to ensure quality interactions along with Case studies from experts who have successfully created and developed a biomarker

The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th - 7th October 2022 in London, UK would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

WHAT TO EXPECT

Key Highlights

  • Clinical biomarker identification and qualification 
  • Biomarkers and personalized medicine 
  • Assay development and validation
  • NGS and novel technologies in biomarker discovery
  • Commercialization of biomarkers in therapeutic and CDx applications

Who Should Attend

  • Researchers, scientists, clinicians, academicians and professionals From Pharmaceutical companies, Bio-pharma companies, Universities and Research Institutes.

Departments:

  • Biomarker discovery/development | Translational research | Clinical Biomarker | Biomarkers in IO and Neurological disorders

CONFERENCE AGENDA
Biomarkers and their Applications
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Speakers
Katerina-Vanessa Savva
Katerina-Vanessa Savva
Researcher, Imperial College London
Heino Heyman
Heino Heyman
Metabolomics Application Specialist, Metabolon
Alain Wagner
Alain Wagner
Co-founder, MicroOmiX Tech
Bart Westendorp
Bart Westendorp
Assistant Professor, Department of Biomolecular Health Sciences, Utrecht University, The Netherlands
Jelmar Quist
Jelmar Quist
Cancer Bioinformatician, King’s College London
Brid Ryan
Brid Ryan
Vice President, MiNA Therapeutics
Sreejith Raveendran
Sreejith Raveendran
Assistant Professor, Teesside University
Patrick Brossard
Patrick Brossard
Principal Clinical Pharmacologist, SOBI
Please contact [email protected] for speaking opportunity
SPONSORS
Gold
example-image

Proteome Sciences

Sponsors & Exhibitors
example-image

Firalis

example-image

Quanterix

example-image

Biognosys

example-image

Olink Proteomics

Speaking Partner
example-image

Hawk Biosystems

example-image

Metabolon

PARTNERS
Supporting Association
California Life Sciences Association (CLSA)

California Life Sciences Association (CLSA)

Media Partners
example-image

Bentham Science

LOCATION
ISH Venues, 1 Park Cres, London W1B 1SH, United Kingdom
About the Hotel

PAST EVENT GALLERY